PARTNERSHIP OPPORTUNITIES
From extensive research in the space, we have found that drug developers are looking for cell line and model providers, instrument providers offering high-resolution analytical tools and innovative software to aid their cell-based assay development and ensure 21CFR compliance
If you provide relevant services or technologies that would benefit our niche, industry-focused audience, now is the time to secure new business and form connections with top biopharma companies seeking solutions to their potency assay bottlenecks in order to progress their products to market.
Get in touch to discover how the 2nd Gene Therapy Potency Assay Summit can help your company win new business, develop relevant collaborations, and ensure critical industry connections for 2024 and beyond
Experts Need Your Help With:
Partner CROs to help with assay selection and validation
Cell Line/Model selection to better replicate environments in vivo
Automation and platform assay solutions to improve sample throughput analysis and efficiency
Novel instrumentation to better link vector biophysical properties, including PTMs, to product potency
And more!
Why Partner?
Meet Industry-Relevant Senior Decision Makers: This meeting will unite 100+ analytical, bioassay, QC, regulatory, and CMC experts creating a niche environment to network directly with scientists and strategists in the space
Gain Brand Visibility by Showcasing your Solutions: Demonstrate your services to a niche, focused group of analytical experts from the leading companies in the gene therapy field, including Sarepta Therapeutics, Sanofi, Ultragenyx, Vertex, J & J, and many others
Learn About Emerging Cell/non-Cell-Based Assay Approaches: Hear from innovative drug developers to uncover market trends and glean critical insights into the future direction of the potency industry
Who Will You Meet?
